Browse
related articles
US, European bourses under pressure
- Monday, June 25 - 2007 at 13:28
US markets were under pressure last week due to concerns about rising bond yields. All indexes suffered a correction with the Dow Jones drawing a double top pattern. Things were no better in Europe with markets losing ground week-on-week. Technically, downward movement should still dominate.
- US: US markets were under pressure week-on-week due to concerns about rising bond yields. All indexes had a corrective week, closing near their session lows, and the Dow has even drawn a double top pattern, calling for further consolidation. Stocks from real estate, consumer services and telecom services were among the worst performers, while semiconductors, automobiles and tech. hardware managed to close on a positive note. From a technical point of view, regarding the configuration of the current correction, a slight further and limited drop should be expected this coming week.
- EUROPE: European markets lost ground week-on-week. All sectors were under pressure, especially shares from travel and leisure, retail, financial services and telecommunications. Only the chemicals sector managed to end in the green. Technically, major European markets should still remain under pressure.
COMPANY PREVIEW
Oracle (USD 19.39 ; -2.37% ; ORCL ; ORCL.O)
On Tuesday, Oracle is seen reporting 4Q EPS of $0.34 ($0.29 last year) on sales of $5.6bln ($4.9bln). At the beginning of June, the Co announced its plan to sell wireless IC tags in China with Hitachi (Nikkei). On June 5, Oracle was chosen by Hewlett Packard to oversee sales to the Co's largest US business customers. Separately, the Co expects to reach $50bln in revenue in the coming years due to acquisitions.
Nike (B) (USD 52.95 ; -0.88% ; NKE ; NKE.N)
On the same day, Nike will post 4Q earnings. 4Q EPS is seen at $0.85 ($0.7 last year) on sales of $4.36bln ($4bln). At the end of May, the Co stated new business targets for 2011 that deeply integrate corporate responsibility goals into the Co's long-term growth and innovation business strategies. The Co aims for the improvement of labour conditions in contract factories and sustainability of product design and innovation.
Monsanto (USD 67.55 ; 4.15% ; MON ; MON.N)
Thursday, Monsanto is expected to publish 3Q EPS of $0.95 ($0.61 last year) on sales of $2.74bln ($2.34bln). Last week, the Co entered into a 3Y research collaboration for insect control on a key class of insects with Athenix. In other news, the Co has also signed long-term business licensing agreements with Bayer CropScience concerning the development of agricultural technologies. Separately, the group boosted its FY07 EPS guidance to $1.75-$1.80 compared with a previous forecast of $1.60-$1.65 ($1.69 consensus).
Biomet (USD 45.5 ; -0.09% ; BMET ; BMET.O)
Still on Thursday, Biomet will release 4Q EPS of $0.48 ($0.46 last year) on sales of $581m ($539m). On June 7, the group agreed to an $11.4bln buyout offer ($46 per share) from the Blackstone Group, KKR, TPG and the Goldman Sachs Group. At the beginning of June, Biomet settled shareholder lawsuits objecting to the Co's agreement to be taken over by a private equity group.
Berkeley Group (GBp 1780 ; -4.04% ; BKG ; BKL.L)
Finally, on Friday, the Berkley Group may announce FY pre-tax profit of £106.1m (£165.1m a year ago) on revenues of £489.9m (£917.9m). In April, the Co formed a joint venture with Saad Investments (Sunday Times). The newspaper added that Saad owns 29.2% of Berkeley. The Cos plan to invest £175m to buy 10,000 plots of land in Britain.
Browse
related articles
- » Nokia N900 to hit UAE stores
- » Abu Dhabi Tourism Authority plans measured expansion for 2010
- » Boeing to showcase tailored portfolio of products and services at Dubai Air Show 2009
- » Burj Dubai enters final leg of construction
- » Marriott International announces the signing of five hotels for its newly established Middle East and Africa region
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AMEinfo.com Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AMEinfo.com Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AMEinfo.com Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AMEinfo.com Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
Internaxx
